Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial
Background Ovarian stimulation (OS) for poor ovarian response (POR) patients is still a major challenge in assisted reproductive techniques. Aromatase inhibitors as co-treatment in antagonist protocol are suggested to these patients, but there are controversial reports. Objecti...
Main Authors: | Ashraf Moini, Zohreh Lavasani, Ladan Kashani, Maryam Farid Mojtahedi, Nazila Yamini |
---|---|
Format: | Article |
Language: | English |
Published: |
Shahid Sadoughi University of Medical Sciences
2019-09-01
|
Series: | International Journal of Reproductive BioMedicine |
Subjects: | |
Online Access: | https://doi.org/10.18502/ijrm.v17i9.5101 |
Similar Items
-
Current evidence supporting "letrozole" for ovulation induction
by: Sujata Kar
Published: (2013-01-01) -
EVALUATION OF LETROZOLE THERAPEUTIC EFFECT IN INFERTILE WOMEN
by: F. Akbary-Asbagh, et al.
Published: (2007-06-01) -
EVALUATION OF LETROZOLE THERAPEUTIC EFFECT IN INFERTILE WOMEN
by: F. Akbary-Asbagh, et al.
Published: (2007-07-01) -
Letrozole versus laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
by: Qiong Yu, et al.
Published: (2019-02-01) -
Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: An RCT
by: Maryam Eftekhar, et al.
Published: (2020-04-01)